FDA Grants Accelerated Approval to Pfizer’s Braftovi Combination for Metastatic Colorectal Cancer

Posted on by admin

Accelerated approval was based on promising results from the ongoing Phase III BREAKWATER trial.

Leave a Reply

Your email address will not be published. Required fields are marked *